NICOLE JOHNSON: Open Payments
NPI 1548745672 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,652 in 74 payments from 17 companies in 2025. Trend: 2023 $2,944 · 2024 $18 · 2025 $1,652
Food & beverage: $1,652
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $299 |
| Otsuka America Pharmaceutical, Inc. | 10 | $212 |
| E.R. Squibb & Sons, L.L.C. | 8 | $187 |
| ABBVIE INC. | 10 | $161 |
| Teva Pharmaceuticals USA, Inc. | 7 | $161 |
| Janssen Pharmaceuticals, Inc | 4 | $115 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Lundbeck LLC | 3 | $92 |
| Alkermes, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
Products named: HETLIOZ, REXULTI, COBENFY, VRAYLAR, AUSTEDO XR, SPRAVATO, Auvelity, ARISTADA.
Industry payments across NC — which companies pay providers there.
